Meet Our Leadership Team
Meet the team that is defining the new era of precision dermatology with innovation, entrepreneurship, passion, and personal experience.
Burkhard Jansen, M.D.
President
Burkhard Jansen, M.D., is the President of DermTech, LLC, where he leads the company’s efforts on strategy and stakeholder outreach to serve the dermatology community and its patients through non-invasive genomic testing for skin cancer. Dr. Jansen has contributed as founder, director, and senior executive of a number of dermatology and oncology focused life sciences companies, in the US, Canada, and Europe. He is a skin cancer expert with a background as a tenured professor of both dermatology and clinical pharmacology with FDA experience. His scientific work is published in leading peer reviewed journals including Nature, Nature Medicine, Lancet, and PNAS. Dr. Jansen received his medical doctorate and dermatology training from the Universities of Graz and Vienna in Austria, his postdoctoral science training at the University of Minnesota, and his executive business education at UCLA.
Loren Clarke, M.D.
Chief Medical Officer
Loren Clarke, M.D., is the Chief Medical Officer at DermTech, LLC, where he leads the company’s clinical and scientific efforts in implementing advanced molecular diagnostics for skin cancer. Dr. Clarke has been at the forefront of the company’s mission to revolutionize dermatological care through non-invasive genomic testing. A board-certified Pathologist and Dermatopathologist, Dr. Clarke brings extensive experience in clinical dermatopathology and molecular diagnostics. Prior to DermTech, he served as faculty at Penn State University’s Hershey Medical Center and contributed to the development of novel molecular diagnostics for melanoma at Myriad Genetics. Dr. Clarke has contributed significantly to the medical and scientific literature, authoring or co-authoring over 60 peer-reviewed publications, as well as numerous book chapters and a textbook on Dermatopathology.
Jeremy Teraoka
Head of Finance
Jeremy Teraoka, is the Head of Finance at DermTech, LLC. Mr. Teraoka is a seasoned finance and operations executive with extensive investment banking and biotech experience across North America, Asia and Europe. Trained in the UK with KPMG, Mr. Teraoka has held CFO, Finance Director, and Controller positions, working in both multinational corporations and fast-growing startups. As a co-founder and executive leader, he scaled the stockbroking firm Asia Equity, leading to its acquisition by Banque Paribas. Mr. Teraoka has a bachelor’s degree in economics and philosophy from University College London (UCL).